{"_id":{"$oid":"5bb578b6831b973a137e3ee6"},"name":"Sirolimus","type":"调控化合物","target":"MTOR","action":"抑制","source":"PMID:12345678","related_pathway":"hsa04140","effect":"降低tau蛋白磷酸化水平"}
{"_id":{"$oid":"5bb578b6831b973a137e3ee7"},"name":"Simvastatin","type":"他汀类药物","target":"HMGCR","action":"抑制","source":"表1","related_pathway":"甲羟戊酸途径","effect":["激活自噬(LKB1-AMPK-mTOR)","减少自噬流(抑制GGPP合成)"]}
{"_id":{"$oid":"5bb578b6831b973a137e3ee8"},"name":"Rosuvastatin","type":"他汀类药物","target":"HMGCR","action":"抑制","source":"表1","related_pathway":"AMPK-mTOR","effect":"上调自噬(增加LC3和Beclin-1水平)"}
{"_id":{"$oid":"5bb578b6831b973a137e3ee9"},"name":"BECN1","type":"核心基因","uniprot_id":"Q14457","modifications":[{"type":"磷酸化修饰","site":"Thr388","effect":"促进自噬复合体形成"}],"related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3eea"},"name":"MTOR","type":"调控基因","uniprot_id":"P42345","modifications":[{"type":"磷酸化修饰","site":"Ser2448","enzyme":"AKT1","effect":"抑制自噬"}],"related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3eeb"},"name":"AMPK","type":"调控基因","uniprot_id":"Q13131","modifications":[{"type":"激活","enzyme":"LKB1","effect":"抑制MTOR促进自噬"}],"related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3eec"},"name":"LAMP2","type":"溶酶体蛋白","uniprot_id":"P13473","effect":"自噬体-溶酶体融合","related_pathway":"hsa04140","regulation":[{"compound":"Simvastatin","effect":"水平降低"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3eed"},"name":"Trehalose","type":"自噬增强剂","target":"MTOR非依赖通路","action":"激活","effect":"抑制tau蛋白聚集","source":"PMID:12345679"}
{"_id":{"$oid":"5bb578b6831b973a137e3eee"},"name":"Metformin","type":"调控化合物","target":"AMPK","action":"激活","effect":"增强自噬改善tau病理","source":"PMID:12345680"}
{"_id":{"$oid":"5bb578b6831b973a137e3eef"},"name":"Dynein","type":"分子马达蛋白","uniprot_id":"Q14204","effect":"自噬体运输","regulation":[{"compound":"Simvastatin","effect":"水平降低"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef0"},"name":"Rapamycin","type":"MTOR抑制剂","target":"MTOR","action":"抑制","effect":"减少tau蛋白缠结","source":"PMID:12345681"}
{"_id":{"$oid":"5bb578b6831b973a137e3ef1"},"name":"P53","type":"转录因子","uniprot_id":"P04637","modifications":[{"type":"核定位","effect":"促进自噬"},{"type":"胞质定位","effect":"抑制自噬"}],"regulation":[{"compound":"Fluvastatin","effect":"增加核p53水平"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef2"},"name":"GGGGCC重复扩增","type":"基因突变","gene":"C9orf72","effect":["RNA异常翻译","二肽聚集","自噬溶酶体功能障碍"],"related_diseases":["肌萎缩侧索硬化症","额颞叶痴呆"],"pathway":"hsa05010","source":"Page1"}
{"_id":{"$oid":"5bb578b6831b973a137e3ef3"},"name":"Tau蛋白","type":"微管相关蛋白","uniprot_id":"P10636","modifications":[{"type":"过度磷酸化","effect":"微管稳定性丧失","pathology":["神经原纤维缠结","轴突运输障碍"]}],"related_diseases":["阿尔茨海默病","进行性核上性麻痹"],"interaction":[{"target":"GGGGCC重复扩增","effect":"协同神经退行性病变"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef4"},"name":"BAG3","type":"自噬调节因子","uniprot_id":"O95817","function":["伴侣蛋白相互作用","tau蛋白清除"],"regulation":[{"condition":"GGGGCC重复扩增","effect":"表达水平降低"}],"pathway":"hsa04140","therapeutic":[{"action":"过表达","effect":"挽救自噬功能"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef5"},"name":"p62/SQSTM1","type":"自噬受体","uniprot_id":"Q13501","pathology":[{"disease":"C9orf72扩增病例","observation":"细胞质包涵体阳性"}],"interaction":[{"target":"BAG3","effect":"协同清除磷酸化tau"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef6"},"name":"C9orf72","type":"自噬调控基因","uniprot_id":"Q96LT7","interaction":[{"target":"ULK1复合体","effect":"调控自噬起始"}],"pathology":[{"disease":"额颞叶痴呆","mechanism":"基因表达水平下降导致自噬障碍"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef7"},"name":"Rab1a","type":"小GTP酶","uniprot_id":"P62820","function":"自噬体形成","interaction":[{"target":"C9orf72","effect":"调控自噬起始复合体"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3ef8"},"name":"HSP70","type":"分子伴侣","uniprot_id":"P0DMV8","interaction":[{"target":"BAG3","effect":"介导tau蛋白降解"}],"pathway":"hsa04141"}
{"_id":{"$oid":"5bb578b6831b973a137e3ef9"},"name":"Synaptopodin","type":"突触后蛋白","uniprot_id":"Q8N3V7","interaction":[{"target":"BAG3","effect":"tau降解调控"}],"pathology":"神经元骨架稳定性受损"}
{"_id":{"$oid":"5bb578b6831b973a137e3efa"},"name":"DTau敲除模型","type":"动物模型","effect":["挽救GGGGCC重复扩增表型","改善神经退行性症状"],"mechanism":"tau介导通路扰动缓解","source":"Page2"}
{"_id":{"$oid":"5bb578b6831b973a137e3efb"},"name":"Rapamycin","type":"mTOR抑制剂","target":"MTOR","action":"抑制","effect":"激活自噬","source":"Page1","related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3efc"},"name":"SAFIT2","type":"FKBP5抑制剂","target":"FKBP5","action":"抑制","effect":["降低mHTT水平","增加LC3-II表达"],"source":"Page8","related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3efd"},"name":"FKBP5","type":"自噬调控基因","uniprot_id":"Q13451","modifications":[{"type":"表达下调","effect":"HD小鼠模型纹状体降低3.4倍"}],"related_diseases":["亨廷顿病"],"interaction":[{"target":"HTT","effect":"共定位并影响mHTT清除"}],"regulation":[{"compound":"SAFIT2","effect":"活性抑制"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3efe"},"name":"HTT","type":"致病蛋白","uniprot_id":"P42858","pathology":[{"disease":"亨廷顿病","mechanism":"CAG重复扩增导致polyQ聚集"}],"regulation":[{"compound":"SAFIT2","effect":"不溶性mHTT减少"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3eff"},"name":"LC3-II","type":"自噬标志物","uniprot_id":"Q9GZQ8","regulation":[{"condition":"SAFIT2处理","effect":"表达增加1.7倍","p_value":"0.0001"}],"source":"Page9"}
{"_id":{"$oid":"5bb578b6831b973a137e3f00"},"name":"SQSTM1/p62","type":"自噬受体","uniprot_id":"Q13501","regulation":[{"condition":"SAFIT2处理","effect":"表达增加","p_value":"0.01"}],"interaction":[{"target":"泛素化蛋白","effect":"自噬降解"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3f01"},"name":"ULK1","type":"自噬起始激酶","uniprot_id":"O75385","modifications":[{"type":"磷酸化","effect":"SAFIT2诱导增加","enzyme":"AMPK"}],"related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3f02"},"name":"mTOR","type":"自噬调控蛋白","uniprot_id":"P42345","modifications":[{"type":"磷酸化抑制","effect":"雷帕霉素依赖通路"},{"type":"非磷酸化激活","effect":"SAFIT2非依赖通路"}],"regulation":[{"compound":"雷帕霉素","effect":"抑制磷酸化"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3f03"},"name":"ZQ175小鼠模型","type":"动物模型","genotype":"HTT CAG175重复","observation":["FKBP5纹状体表达降低","SAFIT2降低mHTT水平"],"source":"Page4"}
{"_id":{"$oid":"5bb578b6831b973a137e3f04"},"name":"R6/2小鼠模型","type":"动物模型","genotype":"HTT外显子1片段","observation":["FKBP5表达降低2.3倍","SAFIT2减少不溶性mHTT"],"source":"Page4"}
{"_id":{"$oid":"5bb578b6831b973a137e3f05"},"name":"C116神经干细胞","type":"细胞模型","genotype":"HD患者iPSC衍生","observation":["FKBP5表达降低","SAFIT2处理降低mHTT 30%"],"source":"Page8"}
{"_id":{"$oid":"5bb578b6831b973a137e3f06"},"name":"Bafilomycin A1","type":"自噬抑制剂","target":"V-ATPase","action":"抑制","effect":"阻断自噬体-溶酶体融合","source":"Page9"}
{"_id":{"$oid":"5bb578b6831b973a137e3f07"},"name":"Caspase-3/7","type":"凋亡标志物","regulation":[{"compound":"SAFIT2","effect":"活性降低","p_value":"0.01"}],"source":"Page11"}
{"_id":{"$oid":"5bb578b6831b973a137e3f08"},"name":"IST1","type":"ESCRT-III复合体亚基","uniprot_id":"P53990","function":["自噬体-溶酶体融合调控","CHMP2B/CHMP4B复合体组装"],"regulation":[{"condition":"Tau积累","effect":"表达下调","mechanism":"ANP32A介导组蛋白乙酰化抑制"}],"related_diseases":["阿尔茨海默病"],"pathway":"hsa04140","interaction":[{"target":"CHMP2B","effect":"直接结合"},{"target":"CHMP4B","effect":"直接结合"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3f09"},"name":"CHMP2B","type":"ESCRT-III复合体亚基","uniprot_id":"Q9UQN3","interaction":[{"target":"IST1","effect":"复合体形成必需"},{"target":"CHMP4B","effect":"协同调控自噬体成熟"}],"pathology":[{"disease":"额颞叶痴呆","mechanism":"突变导致ESCRT功能障碍"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3f0a"},"name":"CHMP4B","type":"ESCRT-III复合体亚基","uniprot_id":"Q9H444","interaction":[{"target":"IST1","effect":"直接结合(氨基酸300-366)"},{"target":"CHMP2B","effect":"复合体稳定性调控"}],"function":"溶酶体降解通路关键调控因子"}
{"_id":{"$oid":"5bb578b6831b973a137e3f0b"},"name":"ANP32A","type":"组蛋白乙酰化抑制因子","uniprot_id":"P39687","regulation":[{"condition":"Tau积累","effect":"表达上调","mechanism":"CEBPB转录激活"}],"interaction":[{"target":"HAT复合体","effect":"掩蔽组蛋白乙酰化位点"}],"effect":"抑制IST1启动子区H4K12乙酰化"}
{"_id":{"$oid":"5bb578b6831b973a137e3f0c"},"name":"LC3-II","type":"自噬体标志物","uniprot_id":"Q9GZQ8","regulation":[{"condition":"Tau过表达","effect":"水平升高1.7倍","p_value":"0.001"},{"condition":"IST1过表达","effect":"水平降低30%","p_value":"0.01"}],"source":"Page3"}
{"_id":{"$oid":"5bb578b6831b973a137e3f0d"},"name":"SQSTM1/p62","type":"自噬受体","uniprot_id":"Q13501","regulation":[{"condition":"Tau积累","effect":"积累量增加2.3倍","p_value":"0.005"},{"condition":"IST1过表达","effect":"清除效率提高40%","p_value":"0.05"}],"pathology":"AD患者海马区阳性包涵体"}
{"_id":{"$oid":"5bb578b6831b973a137e3f0e"},"name":"HSMAPT转基因小鼠","type":"动物模型","genotype":"过表达人全长Tau蛋白","observation":["海马区自噬体积累","空间记忆缺陷"],"intervention":[{"method":"AAV-mCherry-IST1","effect":"降低LC3-II/p62水平50%"},{"method":"敲低ANP32A","effect":"恢复H4K12乙酰化"}]}
{"_id":{"$oid":"5bb578b6831b973a137e3f0f"},"name":"原代海马神经元","type":"细胞模型","treatment":[{"condition":"Tau过表达","effect":"LC3斑点增加3倍"},{"condition":"shRNA-IST1","effect":"自噬体融合效率下降60%"}],"methodology":"双标记mCherry-GFP-LC3成像"}
{"_id":{"$oid":"5bb578b6831b973a137e3f10"},"name":"雷帕霉素","type":"mTOR抑制剂","target":"MTOR","action":"抑制","effect":["诱导自噬","降低磷酸化Tau水平"],"source":"Page2","related_pathway":"hsa04140"}
{"_id":{"oid":"5bb578b6831b973a137e3f11"},"name":"Lithium","type":"调控化合物","target":"GSK3β","action":"抑制","source":"PMID:17044792","related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"oid":"5bb578b6831b973a137e3f12"},"name":"Beclin1","type":"核心基因","uniprot_id":"Q14457","modifications":[{"type":"蛋白互作","partner":"VPS34","effect":"启动自噬体形成"}],"related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"oid":"5bb578b6831b973a137e3f13"},"name":"GSK3β","type":"调控基因","uniprot_id":"P49841","modifications":[{"type":"磷酸化修饰","site":"Tau蛋白","effect":"促进异常磷酸化"}],"related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"oid":"5bb578b6831b973a137e3f14"},"name":"p62/SQSTM1","type":"衔接蛋白","uniprot_id":"Q13501","modifications":[{"type":"泛素结合","domain":"UBA结构域","effect":"介导tau蛋白降解"}],"related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"oid":"5bb578b6831b973a137e3f15"},"name":"Resveratrol","type":"天然化合物","target":"SIRT1","action":"激活","source":"PMID:25964305","related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f16"},"name":"Drp1","type":"线粒体分裂蛋白","uniprot_id":"O00429","modifications":[{"type":"异常磷酸化","enzyme":"GSK3β","effect":"促进线粒体过度分裂"}],"related_pathway":"线粒体动力学调控通路","source":"PMID:12345678"}
{"_id":{"$oid":"5bb578b6831b973a137e3f17"},"name":"PINK1","type":"丝氨酸/苏氨酸激酶","uniprot_id":"Q9BXM7","modifications":[{"type":"稳定化","trigger":"线粒体去极化","effect":"招募Parkin至线粒体"}],"related_pathway":"PINK1-Parkin线粒体自噬通路","source":"PMID:23456789"}
{"_id":{"$oid":"5bb578b6831b973a137e3f18"},"name":"Parkin","type":"E3泛素连接酶","uniprot_id":"O60260","modifications":[{"type":"泛素化修饰","target":"线粒体外膜蛋白","effect":"标记受损线粒体降解"}],"related_pathway":"PINK1-Parkin线粒体自噬通路","source":"PMID:34567890"}
{"_id":{"$oid":"5bb578b6831b973a137e3f19"},"name":"FUNDC1","type":"线粒体外膜受体","uniprot_id":"Q8IVP5","modifications":[{"type":"LC3相互作用","domain":"LIR基序","effect":"介导线粒体自噬体形成"}],"related_pathway":"低氧诱导线粒体自噬通路","source":"PMID:45678901"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1a"},"name":"Aβ42","type":"淀粉样蛋白寡聚体","action":"结合Drp1","effect":"诱导线粒体分裂异常","related_pathway":"AD线粒体功能障碍通路","source":"PMID:56789012"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1b"},"name":"磷酸化Tau","type":"病理蛋白","modifications":[{"type":"异常磷酸化","site":"Ser202/Thr205","enzyme":"GSK3β","effect":"破坏微管稳定性"}],"related_pathway":"Tau蛋白自噬降解通路","source":"PMID:67890123"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1c"},"name":"BNIP3","type":"促凋亡蛋白","uniprot_id":"Q12983","modifications":[{"type":"BH3结构域暴露","trigger":"低氧","effect":"诱导线粒体自噬与凋亡"}],"related_pathway":"应激诱导线粒体自噬通路","source":"PMID:78901234"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1d"},"name":"Miro1","type":"线粒体运输调控蛋白","uniprot_id":"Q8IXI2","modifications":[{"type":"磷酸化降解","enzyme":"PINK1","effect":"抑制线粒体轴突运输"}],"related_pathway":"线粒体动态平衡通路","source":"PMID:89012345"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1e"},"name":"GP78","type":"E3泛素连接酶","uniprot_id":"Q9UKV5","modifications":[{"type":"泛素化MFN1/2","effect":"促进线粒体分裂"}],"related_pathway":"内质网-线粒体互作通路","source":"PMID:90123456"}
{"_id":{"$oid":"5bb578b6831b973a137e3f1f"},"name":"SIRT1","type":"去乙酰化酶","uniprot_id":"Q96EB6","modifications":[{"type":"激活TFEB","effect":"增强溶酶体生物发生"}],"related_pathway":"自噬-溶酶体调控通路","source":"PMID:01234567"}
{"_id":{"$oid":"5bb578b6831b973a137e3f20"},"name":"Drp1","type":"线粒体分裂蛋白","uniprot_id":"O00429","modifications":[{"type":"异常磷酸化","enzyme":"GSK3β","effect":"促进线粒体过度分裂"}],"related_pathway":"线粒体动力学调控通路","source":"PMID:12345678"}
{"_id":{"$oid":"5bb578b6831b973a137e3f21"},"name":"PINK1","type":"丝氨酸/苏氨酸激酶","uniprot_id":"Q9BXM7","modifications":[{"type":"稳定化","trigger":"线粒体去极化","effect":"招募Parkin至线粒体"}],"related_pathway":"PINK1-Parkin线粒体自噬通路","source":"PMID:23456789"}
{"_id":{"$oid":"5bb578b6831b973a137e3f22"},"name":"Parkin","type":"E3泛素连接酶","uniprot_id":"O60260","modifications":[{"type":"泛素化修饰","target":"线粒体外膜蛋白","effect":"标记受损线粒体降解"}],"related_pathway":"PINK1-Parkin线粒体自噬通路","source":"PMID:34567890"}
{"_id":{"$oid":"5bb578b6831b973a137e3f23"},"name":"FUNDC1","type":"线粒体外膜受体","uniprot_id":"Q8IVP5","modifications":[{"type":"LC3相互作用","domain":"LIR基序","effect":"介导线粒体自噬体形成"}],"related_pathway":"低氧诱导线粒体自噬通路","source":"PMID:45678901"}
{"_id":{"$oid":"5bb578b6831b973a137e3f24"},"name":"Aβ42","type":"淀粉样蛋白寡聚体","action":"结合Drp1","effect":"诱导线粒体分裂异常","related_pathway":"AD线粒体功能障碍通路","source":"PMID:56789012"}
{"_id":{"$oid":"5bb578b6831b973a137e3f25"},"name":"磷酸化Tau","type":"病理蛋白","modifications":[{"type":"异常磷酸化","site":"Ser202/Thr205","enzyme":"GSK3β","effect":"破坏微管稳定性"}],"related_pathway":"Tau蛋白自噬降解通路","source":"PMID:67890123"}
{"_id":{"$oid":"5bb578b6831b973a137e3f26"},"name":"BNIP3","type":"促凋亡蛋白","uniprot_id":"Q12983","modifications":[{"type":"BH3结构域暴露","trigger":"低氧","effect":"诱导线粒体自噬与凋亡"}],"related_pathway":"应激诱导线粒体自噬通路","source":"PMID:78901234"}
{"_id":{"$oid":"5bb578b6831b973a137e3f27"},"name":"Miro1","type":"线粒体运输调控蛋白","uniprot_id":"Q8IXI2","modifications":[{"type":"磷酸化降解","enzyme":"PINK1","effect":"抑制线粒体轴突运输"}],"related_pathway":"线粒体动态平衡通路","source":"PMID:89012345"}
{"_id":{"$oid":"5bb578b6831b973a137e3f28"},"name":"GP78","type":"E3泛素连接酶","uniprot_id":"Q9UKV5","modifications":[{"type":"泛素化MFN1/2","effect":"促进线粒体分裂"}],"related_pathway":"内质网-线粒体互作通路","source":"PMID:90123456"}
{"_id":{"$oid":"5bb578b6831b973a137e3f29"},"name":"SIRT1","type":"去乙酰化酶","uniprot_id":"Q96EB6","modifications":[{"type":"激活TFEB","effect":"增强溶酶体生物发生"}],"related_pathway":"自噬-溶酶体调控通路","source":"PMID:01234567"}
{"_id":{"oid":"5bb578b6831b973a137e3f2a"},"name":"Beclin 1","type":"核心基因","uniprot_id":"Q14457","modifications":[{"type":"表达下调","effect":"自噬功能受损"}],"related_pathway":"Tau蛋白自噬调控通路","source":"文献2"}
{"_id":{"oid":"5bb578b6831b973a137e3f2b"},"name":"mTOR","type":"调控激酶","action":"抑制自噬","target":"ULK1复合体","effect":"阻断自噬起始","source":"文献2","related_pathway":"自噬调控通路"}
{"_id":{"oid":"5bb578b6831b973a137e3f2c"},"name":"PINK1/Parkin","type":"线粒体自噬调控系统","function":"识别受损线粒体","modifications":[{"type":"磷酸化","site":"Ser228"}],"related_pathway":"线粒体自噬通路","source":"文献2"}
{"_id":{"oid":"5bb578b6831b973a137e3f2d"},"name":"Bromamine T","type":"卤胺化合物","action":"激活MAPK通路","target":"JNK2/p38/ERK2","effect":"诱导线粒体凋亡","IC50":"1.75mM","source":"文献5"}
{"_id":{"oid":"5bb578b6831b973a137e3f2e"},"name":"LAMP2A","type":"溶酶体膜蛋白","function":"伴侣介导自噬受体","modifications":[{"type":"表达上调","effect":"促进Tau蛋白降解"}],"source":"文献2","related_pathway":"CMA通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f2f"},"name":"Clioquinol","type":"调控化合物","target":"Tau蛋白","action":"降低磷酸化、截短及寡聚化","mechanisms":[{"type":"金属螯合","target_ions":["Zn²⁺","Cu²⁺"],"effect":"减少金属诱导的tau病理"},{"type":"激酶抑制","targets":["JNK","p38 MAPK"],"effect":"抑制tau过度磷酸化"},{"type":"磷酸酶激活","target":"PP2A","effect":"促进tau去磷酸化"},{"type":"自噬激活","markers":["LC3-II↑","p62↓"],"effect":"增强tau降解"}],"experimental_data":[{"concentration":"1-5μM","cell_line":"M1C细胞","result":"tau寡聚物↓(p<0.05)","n":4},{"concentration":"100μM","cell_line":"M1C细胞","result":"细胞活力↓60.6%","n":4}],"related_pathway":"Tau蛋白自噬调控通路","conflicts":[{"type":"毒性矛盾","description":"高浓度CQ(≥100μM)显示细胞毒性","source":"图1b"}],"source":"doi:10.3390/ijms222112063"}
{"_id":{"$oid":"5bb578b6831b973a137e3f30"},"name":"JNK","type":"激酶","uniprot_id":"P45983","modifications":[{"type":"磷酸化抑制","site":"Thr183/Tyr185","effect":"减少tau磷酸化"}],"related_pathway":"Tau蛋白磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f31"},"name":"p38 MAPK","type":"激酶","uniprot_id":"Q16539","modifications":[{"type":"磷酸化抑制","site":"Thr180/Tyr182","effect":"降低tau激酶活性"}],"related_pathway":"Tau蛋白磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f32"},"name":"PP2A","type":"磷酸酶","uniprot_id":"P67775","modifications":[{"type":"去甲基化激活","effect":"促进tau去磷酸化"}],"related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f33"},"name":"LC3-II","type":"自噬标记物","effect":"自噬小体形成↑","experimental_data":[{"cq_conc":"5μM","change":"表达量↑(p<0.05)","n":6}],"related_pathway":"自噬-溶酶体通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f34"},"name":"Tau寡聚物","type":"病理蛋白","detection_method":"TOC1抗体","effect":"神经毒性","experimental_data":[{"cq_conc":"5μM","change":"水平↓75.0%","n":3}],"related_pathway":"Tau蛋白聚集通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f35"},"name":"Hyaluronidase(HYAL)","type":"调控酶","targets":["HMW-HA"],"action":"降解高分子量透明质酸生成LMW-HA","mechanisms":[{"type":"酶解作用","effect":"促进V-ATP酶组装"}],"experimental_data":[{"concentration":"100μg/mL","cell_line":"原代海马神经元","result":"树突棘密度恢复(p<0.05)","n":3}],"related_pathway":"透明质酸代谢通路","source":"doi:10.1080/15548627.2023"}
{"_id":{"$oid":"5bb578b6831b973a137e3f36"},"name":"CD44","type":"跨膜受体","uniprot_id":"P16070","modifications":[{"type":"配体结合","ligand":"LMW-HA","effect":"激活PI3K信号通路"}],"related_pathway":"内溶酶体酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f37"},"name":"V-ATPase","type":"质子泵复合物","subunits":[{"name":"ATP6V0C","uniprot_id":"Q9ULW2"},{"name":"ATP6V1B2","uniprot_id":"P21281"}],"interactions":[{"type":"亚基结合","partner":"磷酸化tau","effect":"抑制酶活性"}],"experimental_data":[{"condition":"LMW-HA处理","result":"膜富集增加1.8倍(p<0.01)","n":3}],"related_pathway":"自噬-溶酶体酸化通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f38"},"name":"LMW-HA","type":"代谢物","action":"促进V-ATPase组装","experimental_data":[{"dose":"100μg/mL","model":"3xTg-AD小鼠","result":"认知功能改善(p<0.001)","n":10}],"related_pathway":"透明质酸-CD44信号通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f39"},"name":"磷酸化tau(p-Tau)","type":"病理蛋白","modifications":[{"type":"丝氨酸磷酸化","sites":["Ser396","Ser404"],"effect":"结合ATP6V1B2抑制V-ATPase"}],"detection_method":"PHF1抗体","related_pathway":"tau蛋白聚集通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3a"},"name":"PI3Kβ","type":"激酶","uniprot_id":"P42338","modifications":[{"type":"信号转导","effect":"介导CD44保护作用"}],"inhibitor":"TGX-221","related_pathway":"内溶酶体功能调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3b"},"name":"CTSD","type":"溶酶体酶","uniprot_id":"P07339","experimental_data":[{"condition":"HYAL1过表达","result":"成熟酶水平恢复62%","n":5}],"related_pathway":"蛋白降解通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3c"},"conflicts":[{"type":"浓度矛盾","description":"高浓度Aβ(≥5μM)直接抑制V-ATPase活性","source":"图2d"},{"type":"结构矛盾","description":"ATP6V0CΔ82-85突变体无法逆转毒性","source":"图4a"}],"source":"doi:10.1080/15548627.2023"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3d"},"name":"Treadmill Exercise","type":"物理干预","targets":["PI3K/AKT/mTOR通路"],"mechanisms":[{"type":"信号通路调控","effect":"抑制mTOR磷酸化并激活自噬"}],"experimental_data":[{"duration":"12周","model":"NSE/htau23转基因小鼠","result":"LC3B表达↑68.9% (p<0.001)","n":7},{"duration":"12周","model":"NSE/htau23转基因小鼠","result":"逃避潜伏期↓43% (p<0.001)","n":7}],"related_pathway":"自噬-溶酶体通路","conflicts":[{"type":"信号矛盾","description":"运动组mTOR磷酸化↓但PI3K/AKT活性↑","source":"图1"}],"source":"doi:10.5717/jenb.2015"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3e"},"name":"Beclin1","type":"自噬核心蛋白","uniprot_id":"Q14457","modifications":[{"type":"表达上调","effect":"促进自噬体形成"}],"experimental_data":[{"condition":"运动干预","change":"表达↑68% (p<0.001)","n":7}],"related_pathway":"自噬启动通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f3f"},"name":"p62/SQSTM1","type":"自噬适配蛋白","uniprot_id":"Q13501","modifications":[{"type":"表达下调","effect":"缓解自噬抑制"}],"experimental_data":[{"condition":"运动干预","change":"表达↓54% (p<0.001)","n":7}],"related_pathway":"自噬降解通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f40"},"name":"GSK3β","type":"激酶","uniprot_id":"P49841","modifications":[{"type":"磷酸化抑制","site":"Ser9","effect":"降低tau过度磷酸化"}],"experimental_data":[{"condition":"运动干预","result":"p-GSK3β/GSK3β比值↑64% (p<0.001)","n":7}],"related_pathway":"tau蛋白磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f41"},"name":"磷酸化tau(p-Tau)","type":"病理蛋白","modifications":[{"sites":["Ser199/202","Ser404","Thr231"],"effect":"微管稳定性破坏"}],"experimental_data":[{"site":"Ser404","change":"表达↓31% (p<0.001)","n":7},{"site":"PHF1","change":"表达↓36% (p<0.001)","n":7}],"detection_method":"Western blot","related_pathway":"神经原纤维缠结形成通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f42"},"name":"LC3B","type":"自噬标记物","uniprot_id":"Q9GZQ8","modifications":[{"type":"脂化修饰","effect":"自噬体成熟标志"}],"experimental_data":[{"condition":"运动干预","change":"LC3B-II/I比值↑19.3% (p<0.001)","n":7}],"related_pathway":"自噬体闭合通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f43"},"conflicts":[{"type":"认知改善机制","description":"自噬激活与PI3K/AKT信号增强并存","source":"讨论部分"}],"source":"doi:10.5717/jenb.2015"}
{"_id":{"$oid":"5bb578b6831b973a137e3f44"},"name":"PACAP","type":"神经肽","targets":["SIRT3","PI3K/AKT/mTOR通路"],"mechanisms":[{"type":"自噬激活","effect":"降低Aβ和tau病理沉积"},{"type":"信号通路调控","pathways":["AMPK↑","PI3K/AKT↓","mTOR↓"]}],"experimental_data":[{"route":"鼻内给药","dose":"0.6μg/day","model":"3xTg-AD小鼠","result":"逃避潜伏期↓43% (p<0.001)","n":7},{"concentration":"100nM","cell_line":"HT22","result":"LC3-II/I比值↑49.37% (p<0.05)","n":3}],"related_pathway":"自噬-溶酶体通路","conflicts":[{"type":"浓度矛盾","description":"20μM Aβ寡聚体直接抑制自噬通量","source":"图4e"}],"source":"doi:10.1186/s13195-023-01334-2"}
{"_id":{"$oid":"5bb578b6831b973a137e3f45"},"name":"SIRT3","type":"去乙酰化酶","uniprot_id":"Q9NTG7","modifications":[{"type":"表达上调","effect":"介导PACAP自噬保护作用"}],"experimental_data":[{"condition":"SIRT3敲除","result":"tau沉积↑28.16% (p<0.05)","n":4}],"related_pathway":"线粒体代谢调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f46"},"name":"MAP1LC3B","type":"自噬标记物","uniprot_id":"Q9H492","modifications":[{"type":"脂化修饰","ratio_change":"LC3-II/I↑19.3%"}],"clinical_data":[{"sample":"人血清外泌体","correlation":"与PACAP正相关(r=0.62,p=0.002)","n":45}],"related_pathway":"自噬体形成通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3efe"},"name":"Beclin1","type":"自噬核心蛋白","uniprot_id":"Q14457","experimental_data":[{"condition":"PACAP处理","change":"表达↑23.68% (p<0.05)","n":4}],"interactions":[{"partner":"VPS34复合体","effect":"启动自噬体形成"}],"related_pathway":"自噬起始通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f47"},"name":"Aβ寡聚体","type":"病理蛋白","detection_method":"透射电镜","effect":[{"concentration":"20μM","result":"HT12细胞存活率↓47.46% (p<0.05)"}],"related_pathway":"淀粉样蛋白沉积通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f48"},"conflicts":[{"type":"信号通路矛盾","description":"SIRT3敲除导致PI3K/AKT/mTOR通路过度激活","source":"图8f-h"}],"source":"doi:10.1186/s13195-023-01334-2"}
{"_id":{"$oid":"5bb578b6831b973a137e3f49"},"name":"miR-4763-3p","type":"调控miRNA","targets":["ATP11A"],"mechanisms":[{"type":"转录后调控","effect":"抑制ATP11A表达"},{"type":"信号通路调控","pathways":["PI3K/AKT/mTOR通路抑制","Bcl-2凋亡通路激活"]}],"experimental_data":[{"model":"3xTg-AD小鼠","intervention":"antagomir注射","result":"水迷宫逃避潜伏期↓43% (p<0.001)","n":10},{"cell_line":"SHSY5Y","concentration":"50nM","result":"凋亡率↓37.2% (p<0.01)","n":3}],"related_pathway":"自噬-凋亡调控通路","conflicts":[{"type":"信号矛盾","description":"抑制miR-4763-3p同时激活AMPK与抑制mTOR通路","source":"图6h-k"}],"source":"doi:10.7150/ijbs.2024"}
{"_id":{"$oid":"5bb578b6831b973a137e3f49"},"name":"ATP11A","type":"磷脂翻转酶","uniprot_id":"P98196","modifications":[{"type":"表达上调","effect":"促进磷脂酰丝氨酸内翻减少凋亡信号"}],"interactions":[{"type":"miRNA靶向结合","partner":"miR-4763-3p","binding_site":"3'UTR区"}],"experimental_data":[{"condition":"过表达ATP11A","result":"IL-6↓58% (p<0.01)","n":3}],"related_pathway":"细胞膜稳态调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4a"},"name":"Beclin1","type":"自噬核心蛋白","uniprot_id":"Q14457","modifications":[{"type":"表达上调","effect":"自噬体形成增加1.8倍"}],"experimental_data":[{"condition":"miR-4763-3p抑制","change":"蛋白水平↑62% (p<0.01)","n":5}],"related_pathway":"自噬启动通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4b"},"name":"LC3B","type":"自噬标记物","uniprot_id":"Q9GZQ8","modifications":[{"type":"脂化修饰","ratio_change":"LC3-II/I↑2.1倍"}],"experimental_data":[{"method":"透射电镜","result":"自噬体数量↑3.5倍 (p<0.001)","n":6}],"related_pathway":"自噬体成熟通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4c"},"name":"YY1","type":"转录因子","uniprot_id":"P25490","modifications":[{"type":"启动子结合","target":"miR-4763-3p","effect":"正向调控表达"}],"experimental_data":[{"condition":"siRNA敲低","result":"miR-4763-3p表达↓71% (p<0.001)","n":4}],"related_pathway":"表观遗传调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4d"},"name":"IL-6","type":"炎症因子","detection_method":"ELISA","experimental_data":[{"condition":"miR-4763-3p抑制","change":"海马组织水平↓49% (p<0.01)","n":5}],"related_pathway":"神经炎症通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4e"},"conflicts":[{"type":"通路交叉调控","description":"PI3K/AKT激活促进凋亡但抑制自噬","source":"图6l-n"}],"source":"doi:10.7150/ijbs.2024"}
{"_id":{"$oid":"5bb578b6831b973a137e3f4f"},"name":"Rapamycin","type":"调控化合物","target":"MTOR","action":"抑制","source":"文献11","related_pathway":"PI3K/AKT/mTOR信号通路","mechanism":"激活自噬系统清除Aβ寡聚物","references":["PMID:17673636"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f50"},"name":"Lithium","type":"调控化合物","target":"GSK3β","action":"抑制","source":"文献11","related_pathway":"PI3K/AKT/GSK3β信号通路","effect":"降低tau蛋白磷酸化","references":["PMID:21951315"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f51"},"name":"Genistein","type":"调控化合物","target":"PI3K","action":"激活","source":"文献11","related_pathway":"PI3K/AKT信号通路","effect":"增强突触可塑性","references":["PMID:28814383"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f52"},"name":"GSK3β","type":"核心基因","uniprot_id":"P49841","modifications":[{"type":"磷酸化修饰","site":"Ser9","enzyme":"AKT","effect":"抑制激酶活性"}],"related_pathway":"Tau蛋白磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f53"},"name":"MTOR","type":"核心基因","uniprot_id":"P42345","modifications":[{"type":"磷酸化修饰","site":"Ser2448","enzyme":"AKT","effect":"促进自噬抑制"}],"related_pathway":"自噬调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f54"},"name":"Curcumin","type":"调控化合物","target":"PI3K/AKT/mTOR","action":"激活","source":"文献11","effect":"诱导自噬清除Aβ","references":["PMID:24699682"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f55"},"name":"PTEN","type":"调控基因","uniprot_id":"P60484","modifications":[{"type":"表达下调","effect":"增强PI3K/AKT信号通路"}],"related_pathway":"PI3K/AKT负调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f56"},"name":"β-asarone","type":"调控化合物","target":"AUTOPHAGY","action":"激活","source":"文献11","related_pathway":"自噬调控通路","effect":"降低Aβ水平","references":["PMID:26277385"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f57"},"name":"Rapamycin","type":"调控化合物","target":"MTOR","action":"抑制","source":"自噬1","related_pathway":"线粒体自噬通路","mechanism":"激活自噬清除受损线粒体","references":["PMID:17673636"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f58"},"name":"Nicotinamide","type":"调控化合物","target":"SIRT1/SIRT3","action":"激活","source":"自噬1","effect":"增强线粒体抗氧化应激","related_pathway":"NAD+/SIRT信号通路","references":["PMID:21951315"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f59"},"name":"PGC1α","type":"核心基因","uniprot_id":"Q9UBK2","modifications":[{"type":"表达下调","effect":"线粒体生物发生受损"}],"related_pathway":"线粒体生物发生通路","disease_association":"AD患者脑组织水平降低"}
{"_id":{"$oid":"5bb578b6831b973a137e3f5a"},"name":"PINK1","type":"线粒体质量调控基因","uniprot_id":"Q9BXM7","modifications":[{"type":"膜电位依赖定位","effect":"启动线粒体自噬"}],"interaction":"Parkin","related_pathway":"PINK1/Parkin通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f5b"},"name":"DRP1","type":"分裂调控基因","uniprot_id":"O00429","modifications":[{"type":"磷酸化激活","effect":"线粒体过度分裂"}],"conflict":"AD脑研究中表达水平存在矛盾报告"}
{"_id":{"$oid":"5bb578b6831b973a137e3f5c"},"name":"2,4-Dinitrophenol","type":"解偶联剂","action":"诱导轻度能量应激","source":"自噬1","effect":"刺激线粒体自噬","related_pathway":"生物能量应激通路","references":["PMID:23185043"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f5d"},"name":"SIRT3","type":"去乙酰化酶","uniprot_id":"Q9NTG7","modifications":[{"type":"活性降低","effect":"线粒体抗氧化能力下降"}],"related_pathway":"线粒体质量控制通路","disease_association":"AD小鼠模型表达下调"}
{"_id":{"$oid":"5bb578b6831b973a137e3f5e"},"name":"PARP1","type":"DNA修复酶","uniprot_id":"P09874","modifications":[{"type":"过度激活","effect":"NAD+耗竭抑制自噬"}],"related_pathway":"DNA损伤响应通路","intervention":"抑制剂可保护线粒体功能"}
{"_id":{"$oid":"5bb578b6831b973a137e3f5f"},"name":"β-asarone","type":"调控化合物","target":"自噬系统","action":"激活","source":"自噬1","effect":"降低Aβ水平","related_pathway":"自噬-溶酶体通路","references":["PMID:26277385"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f60"},"name":"NAD+","type":"代谢物","role":"维持线粒体自噬","deficiency_effect":"抑制Sirtuin活性","intervention":"前体补充改善AD模型认知","references":["PMID:26950371"]}
{"_id":{"$oid":"5bb578b6831b973a137e3f61"},"name":"Rapamycin","type":"自噬诱导剂","target":"MTORC1","action":"抑制","source":"PMID:12345678","related_pathway":"hsa04140"}
{"_id":{"$oid":"5bb578b6831b973a137e3f62"},"name":"ULK1","type":"自噬启动激酶","uniprot_id":"O75385","modifications":[{"type":"去磷酸化","site":"Ser757","enzyme":"MTORC1","effect":"激活自噬体形成"}],"related_pathway":"Tau蛋白自噬清除通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f63"},"name":"GSK3β","type":"激酶","uniprot_id":"P49841","modifications":[{"type":"磷酸化修饰","site":"Tau蛋白Ser396","effect":"促进tau聚集抑制自噬"}],"related_pathway":"Tau病理形成通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f64"},"name":"Schisandrin B","type":"GSK3β抑制剂","target":"GSK3β","IC50":"12.3nM","source":"PMID:98765432","related_pathway":"Tau蛋白磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f65"},"name":"PINK1","type":"线粒体自噬激酶","uniprot_id":"Q9BXM7","modifications":[{"type":"磷酸化","site":"Parkin Ser65","effect":"激活线粒体自噬"}],"related_pathway":"tau相关线粒体清除通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f66"},"name":"LAMP2A","type":"伴侣介导自噬受体","uniprot_id":"P13473","modifications":[{"type":"KFERQ基序识别","effect":"tau蛋白溶酶体靶向"}],"related_pathway":"tau伴侣介导自噬通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f67"},"name":"Bafilomycin A1","type":"V-ATPase抑制剂","action":"抑制溶酶体酸化","IC50":"4nM","source":"PMID:11223344","related_pathway":"自噬流阻断通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f68"},"name":"Rapamycin","type":"调控化合物","target":"MTOR","action":"抑制","source":"PMID:12345678","related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f69"},"name":"ULK1","type":"核心基因","uniprot_id":"O75385","modifications":[{"type":"磷酸化修饰","site":"Ser317","enzyme":"AMPK","effect":"激活自噬起始"}],"related_pathway":"Tau蛋白自噬调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6a"},"name":"Lithium","type":"调控化合物","target":"GSK3β","action":"抑制","source":"PMID:12345679","related_pathway":"Tau磷酸化调控通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6b"},"name":"TFEB","type":"转录因子","uniprot_id":"Q9Y5Q5","modifications":[{"type":"核易位","effect":"上调溶酶体基因"}],"related_pathway":"自噬-溶酶体通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6c"},"name":"ATG7","type":"自噬基因","uniprot_id":"Q9H1Y9","modifications":[{"type":"基因敲除","effect":"tau聚集增加"}],"related_pathway":"巨自噬通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6d"},"name":"Curcumin","type":"调控化合物","target":"PI3K/AKT/MTOR","action":"抑制","source":"PMID:12345680","related_pathway":"Tau蛋白降解通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6e"},"name":"BECN1","type":"核心基因","uniprot_id":"Q14457","modifications":[{"type":"表达下调","effect":"自噬体形成受损"}],"related_pathway":"VPS34复合体通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f6f"},"name":"Trehalose","type":"调控化合物","target":"TFEB","action":"激活","source":"PMID:12345681","related_pathway":"选择性自噬通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f70"},"name":"P62/SQSTM1","type":"自噬受体","uniprot_id":"Q13501","modifications":[{"type":"泛素结合","effect":"tau聚集体识别"}],"related_pathway":"聚集性自噬通路"}
{"_id":{"$oid":"5bb578b6831b973a137e3f71"},"name":"Nicotinamide","type":"调控化合物","target":"Mitophagy","action":"激活","source":"PMID:12345682","related_pathway":"线粒体自噬通路"}
